Join Our Newsletter
Learn more about how PrismRA can help guide your RA treatment with our patient focused newsletter.
By clicking Submit you agree to receive marketing emails from PrismRA
Get PrismRA
Talk to Your Rheumatologist about PrismRA
ABOUT
67%
of patients do not respond to TNFi therapy.*1,2 PrismRA helps guide your medication selection.
You are probably wondering which treatment is right for you.
PrismRA is a blood test ordered by your rheumatologist. Based on the PrismRA result, your doctor may find that a TNF inhibitor therapy or a different type of medication gives you a greater chance of feeling better based on your unique biology.
When starting or changing your RA medication, ask your rheumatologist if PrismRA is right for you. It is important to partner with your rheumatologist to create the right treatment plan.
*Response defined as ACR50 at 6 months.
A Simple Process for Better Therapy Selection
Patients have the best chance for long-term relief when they respond to their medications.3,4 Maximize your window of opportunity and let PrismRA help your doctor find the right medicine for you.
Partner with your rheumatologist to know if PrismRA is right for you
Your doctor orders PrismRA and your blood sample is collected
Your blood sample is sent to and analyzed by the Scipher Medicine lab
The PrismRA result is sent to your doctor within 5-7 business days
Use your PrismRA result to discuss your treatment plan with your doctor
Find a Rheumatology Specialist Who Offers PrismRA
Contact the Scipher Medicine Client Services team to find a specialist in your location:
Learn More About PrismRA
Interested in how PrismRA helps guide therapy decisions? Please contact the Scipher Medicine Client Services team.
References
1. Incerti, D, Jansen, JP. A Description of the IVI-RA Model v2.0. 2020; last updated January 2020. 2. Curtis JR, et al. Semin Arthritis Rheum. 2010;40(1):2-14. 3. Kavanaugh A, et al. Ann Rheum Dis. 2018;77(2):289-292. 4. Scott IC, et al. BMC Rheumatol. 2018;30(2):32.